These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
226 related articles for article (PubMed ID: 7542690)
21. Role of hormonal axis, growth hormone - IGF-1, in the therapeutic effect of ghrelin in the course of cerulein-induced acute pancreatitis. Ceranowicz D; Warzecha Z; Dembinski A; Ceranowicz P; Cieszkowski J; Kusnierz-Cabala B; Tomaszewska R; Kuwahara A; Kato I J Physiol Pharmacol; 2010 Oct; 61(5):599-606. PubMed ID: 21081804 [TBL] [Abstract][Full Text] [Related]
22. Effects of a new cholecystokinin antagonist, TS-941, on experimental acute pancreatitis in rats. Wang Y; Naruse S; Kitagawa M; Ishiguro H; Nakae Y; Yoshikawa T; Hayakawa T Pancreas; 1998 Oct; 17(3):289-94. PubMed ID: 9788544 [TBL] [Abstract][Full Text] [Related]
23. Role of endogenous cholecystokinin and cholecystokinin-A receptors in the development of acute pancreatitis in rats. Tachibana I; Shirohara H; Czako L; Akiyama T; Nakano S; Watanabe N; Hirohata Y; Otsuki M Pancreas; 1997 Mar; 14(2):113-21. PubMed ID: 9057182 [TBL] [Abstract][Full Text] [Related]
24. Fasting prevents acute pancreatitis induced by cerulein in rats. Otsuki M; Tani S; Okabayashi Y; Fujii M; Nakamura T; Fujisawa T; Koide M; Itoh H Dig Dis Sci; 1990 Jul; 35(7):840-8. PubMed ID: 2364838 [TBL] [Abstract][Full Text] [Related]
25. Peptide YY ameliorates cerulein-induced pancreatic injury in the rat. Tito JM; Rudnicki M; Jones DH; Alpern HD; Gold MS Am J Surg; 1993 Jun; 165(6):690-6. PubMed ID: 7685154 [TBL] [Abstract][Full Text] [Related]
26. Effects of loxiglumide on experimental acute pancreatitis in comparison with gabexate mesilate. Kimura K; Tominaga K; Fujii M; Saito T; Kasai H Arzneimittelforschung; 1998 Jan; 48(1):65-9. PubMed ID: 9522035 [TBL] [Abstract][Full Text] [Related]
27. Role of sensory nerves in pancreatic secretion and caerulein-induced pancreatitis. Warzecha Z; Dembiński A; Jaworek J; Ceranowicz P; Szlachcic A; Walocha J; Konturek SJ J Physiol Pharmacol; 1997 Mar; 48(1):43-58. PubMed ID: 9098825 [TBL] [Abstract][Full Text] [Related]
29. Effects of loxiglumide on pancreatic exocrine secretion stimulated by meal in conscious dogs. Ninomiya K; Saito T; Wakatsuki K; Saeki M; Kato T; Edano K; Kasai H; Kimura K; Fujii M Arzneimittelforschung; 1998 Jan; 48(1):55-7. PubMed ID: 9522033 [TBL] [Abstract][Full Text] [Related]
30. Cholecystokinin acts as an essential factor in the exacerbation of pancreatic bile duct ligation-induced rat pancreatitis model under non-fasting condition. Yoshinaga K; Washizuka M; Segawa Y Jpn J Pharmacol; 2000 Sep; 84(1):44-50. PubMed ID: 11043452 [TBL] [Abstract][Full Text] [Related]
31. Dissociation of prostaglandin output from secretin-stimulated exocrine secretion of the pancreas in dogs. Iwatsuki K; Horiuchi A; Yonekura H; Kuroda T; Chiba S Arch Int Pharmacodyn Ther; 1988; 291():263-71. PubMed ID: 2452610 [TBL] [Abstract][Full Text] [Related]
32. Beneficial effects of the synthetic trypsin inhibitor camostate in cerulein-induced acute pancreatitis in rats. Otsuki M; Tani S; Okabayashi Y; Fuji M; Nakamura T; Fujisawa T; Itoh H Dig Dis Sci; 1990 Feb; 35(2):242-50. PubMed ID: 1689237 [TBL] [Abstract][Full Text] [Related]
33. Effects of loxiglumide on pancreatic exocrine secretion stimulated by cholecystokinin-8 in conscious dogs. Ninomiya K; Saito T; Wakatsuki K; Saeki M; Kato T; Kasai H; Kimura K; Fujii M Arzneimittelforschung; 1998 Jan; 48(1):52-4. PubMed ID: 9522032 [TBL] [Abstract][Full Text] [Related]
34. Effects of octreotide pretreatment in experimental acute pancreatitis. Salem MZ; Cunha JE; Coelho AM; Sampietri SN; Machado MC; Penteado S; Abdo EE Pancreatology; 2003; 3(2):164-8. PubMed ID: 12748426 [TBL] [Abstract][Full Text] [Related]
35. Effect of T-0632, a cholecystokininA receptor antagonist, on experimental acute pancreatitis. Taniguchi H; Yomota E; Kume E; Shikano T; Endo T; Nagasaki M Jpn J Pharmacol; 1997 Feb; 73(2):105-12. PubMed ID: 9074944 [TBL] [Abstract][Full Text] [Related]
36. Histologic and biochemical alterations in experimental acute pancreatitis induced by supramaximal caerulein stimulation. Tani S; Otsuki M; Itoh H; Fujii M; Nakamura T; Oka T; Baba S Int J Pancreatol; 1987; 2(5-6):337-48. PubMed ID: 2447208 [TBL] [Abstract][Full Text] [Related]
37. Effectiveness of interleukin-1 receptor antagonist (Anakinra) on cerulein-induced experimental acute pancreatitis in rats. Kaplan M; Yazgan Y; Tanoglu A; Berber U; Oncu K; Kara M; Demirel D; Kucuk I; Ozari HO; Ipcioglu OM Scand J Gastroenterol; 2014 Sep; 49(9):1124-30. PubMed ID: 24912987 [TBL] [Abstract][Full Text] [Related]
38. Microsurgical evaluation of experimental pancreatitis after allopurinol: a secretory serological and morphological study. Brunelli A Pancreas; 1995 Jul; 11(1):55-62. PubMed ID: 7545294 [TBL] [Abstract][Full Text] [Related]
39. Caerulein-induced acute pancreatitis in the rat. Pancreatic secretory response to cholecystokinin. San Román JI; De Dios I; Manso MA; Calvo JJ; López MA Arch Int Physiol Biochim; 1990 Oct; 98(5):237-43. PubMed ID: 1708991 [TBL] [Abstract][Full Text] [Related]
40. Effects of pancreatic duct ligation and aging on acute taurocholate-induced pancreatitis. Experiments in the perfused pancreas in rats. Kimura W; Okubo K; Han I; Kanai S; Matsushita A; Muto T; Miyasaka K Int J Pancreatol; 1996 Apr; 19(2):117-27. PubMed ID: 8723554 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]